Literature DB >> 6187179

Carcino-embryonic antigen (CEA) in gastric adenocarcinomas. Morphologic patterns and their relationship to a histogenetic classification.

K Nielsen, P S Teglbjaerg.   

Abstract

The presence of carcino-embryonic antigen (CEA) was studied in 92 consecutive cases of gastric adenocarcinoma, using the two-layer conjugated immunoperoxidase technique. Three characteristic patterns of CEA localization were identified. Type I: Intracytoplasmatic granules covering the entire cytoplasm of the malignant cells. Type II. Linear or granular deposits along the glycocalyx or in the apical cytoplasm of the malignant cells. Type III: Tumour cells negative for CEA or only showing a very weak reaction in a few cells. These CEA patterns were significantly related to the histogenetic classification of gastric adenocarcinomas proposed by Mulligan & Rember. The majority of the "mucus cell carcinomas" showed the type I CEA pattern. "Intestinal cell carcinomas" predominantly showed the type II CEA pattern and the "pyloro-cardiac gland carcinomas" the type III CEA pattern. The significance of the CEA patterns in respect of the histogenetic classification is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6187179

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand A        ISSN: 0108-0164


  3 in total

1.  Localization of CEA, HCG, lysozyme, alpha-1-antitrypsin, and alpha-1-antichymotrypsin in gastric cancer and prognosis.

Authors:  C Wittekind; R Wachner; W Henke; S von Kleist
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Concentration and distribution of tumor associated antigens TAG-72 and CEA in stomach cancer.

Authors:  J K Chung; M C Lee; H K Chung; S M Lim; J J Jang; C S Koh
Journal:  Ann Nucl Med       Date:  1995-02       Impact factor: 2.668

3.  Evaluation of gastric carcinoembryonic antigen analysis as an aid during screening for gastric neoplasia in atrophic gastritis.

Authors:  K Borch; H Renvall; C Lundin; B Wahren
Journal:  Gut       Date:  1987-01       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.